ICN Pharmaceuticals confirmed earlier reports that it...

ICN Pharmaceuticals confirmed earlier reports that it is considering acquiring up to 25% of a West German pharmaceutical firm, Schering AG. The Costa Mesa company said in a statement that the move was part of a 3-year effort to expand its marketing capabilities.